Method for treating secondary hyperparathyroidism in CKD
US9408858B2 · kind B2 · utility
17Cited by
104References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 17, 2015 |
| Grant date | Aug 9, 2016 |
| Priority date | — |
| Expiry date | Apr 17, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable, controlled release formulation for oral dosing of vitamin D compounds is disclosed. The formulation is prepared by incorporating one or more vitamin D compounds into a solid or semi-solid mixture of waxy materials. Oral dosage forms can be prepared by melt-blending the components described herein and filling gelatin capsules with the formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.